Fingerprint Dive into the research topics where IM-Hem Onc BMT is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.


    Research Output

    Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results

    Byrd, J. C., Wierda, W. G., Schuh, A., Devereux, S., Chaves, J. M., Brown, J. R., Hillmen, P., Martin, P., Awan, F. T., Stephens, D. M., Ghia, P., Barrientos, J., Pagel, J. M., Woyach, J. A., Burke, K., Covey, T., Gulrajani, M., Hamdy, A., Izumi, R., Frigault, M. M. & 5 others, Patel, P., Rothbaum, W., Wang, M. H., O'Brien, S. & Furman, R. R., Apr 9 2020, In : Blood. 135, 15, p. 1204-1213 10 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations
    Open Access
  • Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation

    Hamadani, M., Khanal, M., Ahn, K. W., Litovich, C., Chow, V. A., Eghtedar, A., Karmali, R., Winter, A., Fenske, T. S., Sauter, C., Kharfan-Dabaja, M. A. & Awan, F. T., Jun 2020, In : Biology of Blood and Marrow Transplantation. 26, 6, p. 1099-1105 7 p.

    Research output: Contribution to journalArticle